Limosilactobacillus fermentum LF5 (CNCM I-789) (formerly Lactobacillus fermentum)
Gastroenterology
GUT DYSBIOSIS
Inhibits growth of Candida [in vitro]
Blend
Finished dosage form
a) Deidda F. et al. The In Vitro Effectiveness of Lactobacillus fermentum Against Different Candida Species Compared With Broadly Used Azoles. 2016 J Clin Gastroenterol 50:S171-S174. DOI: 10.1097/MCG.0000000000000686
Gynecology
VAGINAL DYSBIOSIS
Supports vaginal health
Supports a healthy vaginal microbiota
Inhibits vaginal pathogens Candida and G. vaginalis [in vitro]
1, 2, 3, 4) 1 billion CFU
Blend
Finished dosage form
1) Presidio Ospedaliero Delmati, Divisione di Ostetricia - Ginecologia. LF5 - LAB: studio di tollerabilità locale e di attività in pazienti affette da Candida albicans. 1992.
2) Centro di ricerca: USSL Lombardia 55 - Presidio Ospedaliero Delmati, S. Angelo Lodigiano, Divisione di Ostetricia-Ginecologia, Primario: Dott. Francesco Rovere. LF5 (lAB): Studio di dose range finding in pazienti affette da Candida albicans. 1992.
3) Donini G. Studio clinico sull’efficacia e la tollerabilità di LF5 (LAB) capsule vaginali in confronto a placebo in pazienti affette da Candida Albicans. Ospedale S. Salvatore, Divisione Ostetrico-Ginecologica, Pesaro. 1992.
4) Rovere F. Local tolerability and activity study in patients suffering from Candida albicans (“Delmati2 Hospital, Italy, 1992).
a) Deidda F. et al. The In Vitro Effectiveness of Lactobacillus fermentum Against Different Candida Species Compared With Broadly Used Azoles. 2016 J Clin Gastroenterol 50:S171-S174. DOI: 10.1097/MCG.0000000000000686
b) Deidda F. et al. In Vitro Activity of Lactobacillus fermentum LF5 Against Different Candida Species and Gardnerella vaginalis A New Perspective to Approach Mixed Vaginal Infections? J Clin Gastroenterol Volume 50, Supp. 2, November/December 2016. DOI: 10.1097/MCG.0000000000000692
c) Amoruso A. et al. Probiotics as a Valid Strategy for Vaginal Application. Poster from the 15th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health – IPC2022, held in Bratislava on 27-30 June 2022
d) Morazzoni et al. Probiotics and Vaginal Health: A Potential Strategy Against Vaginal Infections. Poster from the 14th International Symposium on Lactic Acid Bacteria, held in Egmond aan Zee NL, 27-31 August 2023.
e) Visciglia A, et al. Characterization of Lactobacillus - Strains for Vaginal Women’s Health. Poster from the 12th Probiotics, Prebiotics, and New Food Congress held in Rome September 16-19, 2023
